Cite
Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab.
MLA
Zhou, Cong, et al. “Systematic Analysis of Circulating Soluble Angiogenesis-Associated Proteins in ICON7 Identifies Tie2 as a Biomarker of Vascular Progression on Bevacizumab.” British Journal of Cancer, vol. 115, no. 2, July 2016, pp. 228–35. EBSCOhost, https://doi.org/10.1038/bjc.2016.194.
APA
Zhou, C., Clamp, A., Backen, A., Berzuini, C., Renehan, A., Banks, R. E., Kaplan, R., Scherer, S. J., Kristensen, G. B., Pujade-Lauraine, E., Dive, C., & Jayson, G. C. (2016). Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab. British Journal of Cancer, 115(2), 228–235. https://doi.org/10.1038/bjc.2016.194
Chicago
Zhou, Cong, Andrew Clamp, Alison Backen, Carlo Berzuini, Andrew Renehan, Rosamonde E Banks, Richard Kaplan, et al. 2016. “Systematic Analysis of Circulating Soluble Angiogenesis-Associated Proteins in ICON7 Identifies Tie2 as a Biomarker of Vascular Progression on Bevacizumab.” British Journal of Cancer 115 (2): 228–35. doi:10.1038/bjc.2016.194.